S37P (p.Ser37Pro) variant of TP53 (Cellular tumor antigen p53)

S37P (p.Ser37Pro) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in a sporadic cancer. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes experimental measurements and structural context.

S37P (p.Ser37Pro) variant details